Improved Pain Management in Knee Osteoarthritis-related Surgeries

Sponsor
Peng Liu (Other)
Overall Status
Completed
CT.gov ID
NCT06124170
Collaborator
(none)
714
1
84
8.5

Study Details

Study Description

Brief Summary

In recent years, pain management coordinated with enhanced recovery after surgery (ERAS) has been widely applied and rapidly developed in orthopedics, showing promising prospects. Since 2016, our hospital has used a series of continuously improved pain management schemes for patients with knee OA who underwent total knee arthroplasty (TKA), unicompartmental knee arthroplasty (UKA), and high tibial osteotomy (HTO). Here, we retrospectively analyze these patients' clinical data to compare the effects of different pain intervention measures during the perioperative period on postoperative pain, functional exercise, hospital stay, and prognosis of the three surgical methods in an attempt to provide a feasible solution for pain management of these patients.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Preoperative pain managment
  • Procedure: Intraoperative pain managment
  • Procedure: Postoperative pain managment

Detailed Description

We retrospectively analyzed the clinical data of patients with knee osteoarthritis (OA) who received surgical treatment to provide a feasible solution for perioperative pain management of these patients. The medical records of 714 patients with knee OA who had undergone total knee arthroplasty (n=551), unicompartmental knee arthroplasty (n=92) and high tibial osteotomy (n=71) were retrospectively analyzed and the cases were divided into Groups A, B, and C, according to the continuously optimized pain management. Clinical data including anesthesia grade, surgery time, functional exercise, hospital stay, pain, emotion, complications and prognosis were compared.

Study Design

Study Type:
Observational
Actual Enrollment :
714 participants
Observational Model:
Case-Control
Time Perspective:
Retrospective
Official Title:
Evaluating the Effectiveness of Continuously Improved Pain Management in Knee Osteoarthritis-related Surgeries
Actual Study Start Date :
Mar 1, 2016
Actual Primary Completion Date :
Mar 2, 2022
Actual Study Completion Date :
Mar 2, 2023

Arms and Interventions

Arm Intervention/Treatment
Total knee arthroplasty (TKA)

Total knee arthroplasty

Procedure: Preoperative pain managment
propaganda and education on pain; Preemptive analgesia with celecoxib (200 mg bid) 2 days before surgery

Procedure: Intraoperative pain managment
Squeeze to expel blood (tourniquet); Before skin suture, 20 mL 0.5% ropivacaine was given subcutaneously for local infiltration anesthesia;

Procedure: Postoperative pain managment
The intravenous analgesia pump was placed until 48 h after surgery;On the second day after surgery, celecoxib (200 mg bid) was administered orally, and buprenorphine transdermal patch was applied externally until hospital discharge;FNB catheter was placed under the guidance of ultrasound and connected with an analgesic pump, the anesthesia lasted until 48 h after surgery ‡

Unicompartmental knee arthroplasty (UKA)

Unicompartmental knee arthroplasty

Procedure: Preoperative pain managment
propaganda and education on pain; Preemptive analgesia with celecoxib (200 mg bid) 2 days before surgery

Procedure: Intraoperative pain managment
Squeeze to expel blood (tourniquet); Before skin suture, 20 mL 0.5% ropivacaine was given subcutaneously for local infiltration anesthesia;

Procedure: Postoperative pain managment
The intravenous analgesia pump was placed until 48 h after surgery;On the second day after surgery, celecoxib (200 mg bid) was administered orally, and buprenorphine transdermal patch was applied externally until hospital discharge;FNB catheter was placed under the guidance of ultrasound and connected with an analgesic pump, the anesthesia lasted until 48 h after surgery ‡

High tibial osteotomy (HTO)

High tibial osteotomy

Procedure: Preoperative pain managment
propaganda and education on pain; Preemptive analgesia with celecoxib (200 mg bid) 2 days before surgery

Procedure: Intraoperative pain managment
Squeeze to expel blood (tourniquet); Before skin suture, 20 mL 0.5% ropivacaine was given subcutaneously for local infiltration anesthesia;

Procedure: Postoperative pain managment
The intravenous analgesia pump was placed until 48 h after surgery;On the second day after surgery, celecoxib (200 mg bid) was administered orally, and buprenorphine transdermal patch was applied externally until hospital discharge;FNB catheter was placed under the guidance of ultrasound and connected with an analgesic pump, the anesthesia lasted until 48 h after surgery ‡

Outcome Measures

Primary Outcome Measures

  1. visual analogue score (VAS) [24 hours after surgery]

    visual analogue score (VAS)

  2. visual analogue score (VAS) [72 hours after surgery]

    visual analogue score (VAS)

Secondary Outcome Measures

  1. Quadriceps muscle strength [24 hours after surgery]

    Quadriceps muscle strength

  2. Quadriceps muscle strength [72 hours after surgery]

    Quadriceps muscle strength

  3. Scope of activities to knee joint [24 hours after surgery]

    Scope of activities to knee joint

  4. Scope of activities to knee joint [72 hours after surgery]

    Scope of activities to knee joint

Other Outcome Measures

  1. Self-Rating Anxiety Scale (SAS) [24 hours after surgery]

    Self-Rating Anxiety Scale (SAS)

  2. Self-Rating Anxiety Scale (SAS) [72 hours after surgery]

    Self-Rating Anxiety Scale (SAS)

  3. Self-Rating Depression Scale (SDS) [24 hours after surgery]

    Self-Rating Depression Scale (SDS)

  4. Self-Rating Depression Scale (SDS) [72 hours after surgery]

    Self-Rating Depression Scale (SDS)

Eligibility Criteria

Criteria

Ages Eligible for Study:
50 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • first knee surgery were 50-80 years old had complete clinical and follow-up data
Exclusion Criteria:
  • American Society of Anesthesiologists Physical Status grade≥4 comorbidity with three or more systemic diseases long-term anxiety and depression, contraindications of painkillers, long-term alcoholism, or taking painkillers concomitant limb pain caused by spinal degeneration

Contacts and Locations

Locations

Site City State Country Postal Code
1 Sichuan Provincial People's Hospital Chengdu Sichuan China 610072

Sponsors and Collaborators

  • Peng Liu

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Peng Liu, Professor, Sichuan Provincial People's Hospital
ClinicalTrials.gov Identifier:
NCT06124170
Other Study ID Numbers:
  • 2023-414
First Posted:
Nov 9, 2023
Last Update Posted:
Nov 9, 2023
Last Verified:
Nov 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 9, 2023